Literature DB >> 15723086

How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!

M B A Heemskerk1, S M van Walraven, J J Cornelissen, R M Y Barge, R G M Bredius, R M Egeler, J L W Tj Lie, T Révész, K Sintnicolaas, N M Wulffraat, A E Donker, P M Hoogerbrugge, J J van Rood, F H J Claas, M Oudshoorn.   

Abstract

Many patients do not reach haematopoietic stem cell transplantation. Shortage of unrelated donors (UDs) is still seen as the main cause. However, with a worldwide UD pool containing more than 8 million donors, it is possible that other impediments are becoming more important. We analysed 549 UD searches for Dutch patients, performed between 1987 and 2000, in order to find the reasons for failure or success to reach transplantation. Between 1996 and 2000, 59% of the patients of Northwest European origin received a graft from an UD with a median time span of 4.4 months from the start of the search. In all, 11% of the patients lacked a compatible donor, while 30% became medically unfit for transplantation. This is in contrast to the patients of non-Northwest European origin for whom UD shortage is still the most important impediment; only 32% were transplanted while 50% lacked a compatible donor. We conclude that the shortage of donors is no longer the biggest constraint in unrelated stem cell transplantation for patients of Northwest European origin. It may be more effective to optimize the chance on transplantation by making the search process more efficient.

Entities:  

Mesh:

Year:  2005        PMID: 15723086     DOI: 10.1038/sj.bmt.1704865

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  17 in total

1.  Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients.

Authors:  Kazuhiro Ikegame; Katsuji Kaida; Satoshi Yoshihara; Masayuki Fujiwara; Kyoko Taniguchi; Ruri Kato; Takayuki Inoue; Tatsuya Fujioka; Hiroya Tamaki; Masaya Okada; Toshihiro Soma; Norihiko Kamikonya; Hiroh Saji; Shozo Hirota; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2012-05-25       Impact factor: 2.490

2.  Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage.

Authors:  R N Lown; S G E Marsh; G E Switzer; K A Latham; J A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

3.  Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1.

Authors:  Jurjen Versluis; Myriam Labopin; Annalisa Ruggeri; Gerard Socie; Depei Wu; Liisa Volin; Didier Blaise; Noel Milpied; Charles Craddock; Ibrahim Yakoub-Agha; Johan Maertens; Per Ljungman; Anne Huynh; Mauricette Michallet; Eric Deconinck; Patrice Chevallier; Jakob Passweg; Fabio Ciceri; Mohamad Mohty; Jan J Cornelissen; Arnon Nagler
Journal:  Blood Adv       Date:  2017-02-28

4.  The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age.

Authors:  Lujia Dong; Tong Wu; Zhi-Yong Gao; Mei-Jie Zhang; Fangyu Kan; Stephen R Spellman; Xi-You Tan; Yan-Li Zhao; Jing-Bo Wang; Dao-Pei Lu; David Miklos; Effie Petersdorf; Marcelo Fernandez-Vina; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2010-12-27       Impact factor: 5.742

5.  Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.

Authors:  R N Lown; J Philippe; W Navarro; S M van Walraven; L Philips-Johnson; M Fechter; R Pawson; M Bengtsson; M Beksac; S Field; H Yang; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-04-07       Impact factor: 5.483

6.  Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.

Authors:  Joseph Pidala; Tatenda G Mupfudze; Tammy Payton; Juliet Barker; Miguel-Angel Perales; Bronwen E Shaw; Marcelo Fernández-Viña; Linda J Burns; Jason Dehn
Journal:  Biol Blood Marrow Transplant       Date:  2019-08-13       Impact factor: 5.742

7.  The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

Authors:  Suzanna M van Walraven; Anneke Brand; Jack N A Bakker; Martin B A Heemskerk; Suzan Nillesen; Marc B Bierings; Laura B Bungener; Bouke G Hepkema; Arjan Lankester; Arnold van der Meer; Kees Sintnicolaas; Judith A E Somers; Eric Spierings; Marcel G J Tilanus; Christien E M Voorter; Jan J Cornelissen; Machteld Oudshoorn
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941

8.  Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination status.

Authors:  Naomi Kawashima; Satoshi Nishiwaki; Naoko Shimizu; Sonoko Kamoshita; Kyoko Watakabe; Emi Yokohata; Shingo Kurahashi; Yukiyasu Ozawa; Koichi Miyamura
Journal:  Int J Hematol       Date:  2018-01-27       Impact factor: 2.490

9.  Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?

Authors:  Sergio Querol; Ghulam J Mufti; Steven G E Marsh; Antonio Pagliuca; Ann-Margaret Little; Bronwen E Shaw; Robert Jeffery; Joan Garcia; John M Goldman; J Alejandro Madrigal
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

Review 10.  How to select the best available related or unrelated donor of hematopoietic stem cells?

Authors:  Jean-Marie Tiercy
Journal:  Haematologica       Date:  2016-05-31       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.